top of page
Rybelsus (generic name: Semaglutide) is a GLP-1 agonist FDA approved for the treatment of type 2 diabetes.
Rybelsus®
Daily oral pill
Disclaimer: Please note that the following list may not encompass all potential side effects or drug interactions. To determine if any drug or supplement you are currently taking could interact with a medication, we strongly advise consulting your healthcare provider or pharmacist. Seek medical advice immediately if you experience any adverse reaction.
bottom of page